Siemens Healthineers AG Share Price Deutsche Boerse AG

Equities

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Market Closed - Deutsche Boerse AG 19:59:09 31/05/2024 BST 5-day change 1st Jan Change
53.56 EUR -0.45% Intraday chart for Siemens Healthineers AG +0.49% +0.87%

Financials

Sales 2024 * 22.68B 24.59B 1,931B Sales 2025 * 24.25B 26.3B 2,065B Capitalization 59.56B 64.59B 5,072B
Net income 2024 * 2.02B 2.19B 172B Net income 2025 * 2.56B 2.77B 218B EV / Sales 2024 * 3.15 x
Net Debt 2024 * 11.87B 12.88B 1,011B Net Debt 2025 * 10.52B 11.41B 896B EV / Sales 2025 * 2.89 x
P/E ratio 2024 *
29.7 x
P/E ratio 2025 *
23.4 x
Employees 71,000
Yield 2024 *
1.92%
Yield 2025 *
2.32%
Free-Float 23.56%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.45%
1 week+0.49%
1 month+3.64%
3 months-3.18%
6 months+0.87%
Current year+0.87%
More quotes
1 week
53.20
Extreme 53.2
54.22
1 month
49.85
Extreme 49.85
54.46
Current year
49.85
Extreme 49.85
58.16
1 year
44.46
Extreme 44.46
58.16
3 years
40.53
Extreme 40.53
67.88
5 years
28.51
Extreme 28.505
67.88
10 years
28.51
Extreme 28.505
67.88
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 31/12/17
Director of Finance/CFO 57 31/12/17
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 31/10/22
Director/Board Member 57 22/03/21
Director/Board Member 72 28/02/18
More insiders
Date Price Change Volume
31/05/24 53.56 -0.45% 150
30/05/24 53.8 +0.30% 78
29/05/24 53.64 -1.07% 302
28/05/24 54.22 +1.08% 184
27/05/24 53.64 +0.64% 1,060

Delayed Quote Deutsche Boerse AG, May 31, 2024 at 07:59 pm

More quotes
Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
53.38 EUR
Average target price
60.47 EUR
Spread / Average Target
+13.28%
Consensus